Digitek Lawsuits filed for Digitek, Bertek & UDL Digoxin Injuries & Deaths

Due to large numbers of Digitek users that have experienced digitalis toxicity and others that have lost loved ones due to Digitek overdose / Digitalis Toxicity, the Willis Law Firm is representing dozens of Digitek victims and their families in Digitek lawsuit litigation. We intend to file a Digitek lawsuit against the manufacturers and distributors of Digetek, Bertek & UDL Digoxin products that are included in the FDA recall namely Mylan, Actavis, & UDL.

FDA Recall of Digitek

Morristown, NJ -- April 25, 2008 -- Actavis Totowa LLC, a United States manufacturing division of the international generic pharmaceutical company Actavis Group, is initiating a Class I nationwide recall of DigitekŪ (digoxin tablets, USP, all strengths) for oral use. The products are distributed by Mylan Pharmaceuticals Inc., under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label. (See:FDA Recall of Digitek.)

What is Digitek or Digitalis?

DigitekŪ is used to treat heart failure and abnormal heart rhythms. The existence of double strength tablets poses a risk of digitalis toxicity in patients with renal failure. Digitalis toxicity can cause nausea, vomiting, dizziness, low blood pressure, cardiac instability and bradycardia. Death can also result from excessive Digitalis intake. FDA has received many reports of serious illnesses and injuries regarding digitalis toxicity. (See:Digitek Overdose Side Effects) The voluntary all lot recall is due to the possibility that tablets with double the appropriate thickness may have been commercially released. These Digitek tablets may contain two times the approved level of active ingredient than it appropriate.

Digoxin Overdose Death Lawsuit - Contact a Lawyer

If you or a loved one have been seriously injured or a loved one has died as a result of this digitalis toxicity or an overdose of Digitek, Bertek and/or UDL Digoxin, please contact us immediately for a Free Digitek Lawsuit Evaluation

Nationwide Help is Available

What is Digoxin or Digitalis?

Digoxin also known as Digitalis, is a purified cardiac glycoside extracted from the foxglove plant. It works by affecting certain minerals (sodium and potassium) inside the cells of the heart. This reduces strain on the heart and helps it beat more strongly Digoxin is widely used in the treatment of various heart conditions, namely atrial fibrillation, atrial flutter and sometimes heart failure that cannot be controlled by other medication. Digoxin preparations are commonly marketed under the trade names Lanoxin, Digitech, and Lanoxicaps.

Digitek Recall

Actavis Totowa LLC, a division of Actavis Group, is initiating a Class I nationwide recall of DigitekŪ (digoxin tablets, USP, all strengths) for oral use. The products are distributed by Mylan Pharmaceuticals Inc., under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label. Actavis manufactures the products for Mylan and the products are distributed by Mylan and UDL under the Bertek and UDL labels. Bertek and UDL are affiliates of Mylan. Digitek lawsuits are being filed

The voluntary recall of Digitek includes all lots, due to the possibility that Digetek tablets were made with double the appropriate thickness may have been commercially released. These tablets may contain twice the approved level of active ingredient than it appropriate which can result in digitalis toxicity, nausea, vomiting, dizziness, low blood pressure, cardiac instability, bradycardia and death. DigitekŪ is used to treat heart failure and abnormal heart rhythms. The existence of double strength tablets poses a risk of digitalis toxicity in patients with renal failure

Digitek Lawsuits - Contact a Lawyer

If you or a loved one have been seriously injured or a loved one has died as a result of this digitalis toxicity or an overdose of Digitek, please call us immediately for a Free Digitek Recall Lawsuit Evaluation to learn more information on whether your case should be filed as a separate lawsuit or part of a global Digitek Class Action Lawsuit. Get the facts about which is best for you.

Nationwide Help is Available

Mylan's Bertek Digoxin & UDL Digoxin Recall Announced by FDA

FDA has announced a Class 1 recall of all Digitek (digoxin) tablets. These Digitek tablets may contain two (2) times as much of digoxin causing potential digitalis toxicity, which can result in nausea, rapid heart beat, vomiting, lo blood pressure, cardiac instability, bradycardia and even death.

Digitek is a registered trademark of Actavis Totowa (formerly Amide Pharmaceutical, Inc.) for their digoxin tablets, which are prescribed to treat heart failure and abnormal heart rhythms. The drug is distributed by Mylan Pharmaceuticals Inc., under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label.

DigitekŪ is used to treat heart failure and abnormal heart rhythms. The existence of double strength tablets poses a risk of digitalis toxicity in patients with renal failure. Digitalis toxicity can cause nausea, vomiting, dizziness, low blood pressure, cardiac instability and bradycardia. Death can also result from excessive Digitalis intake. Several reports of illnesses and injuries have been received. ( See: Digitek Overdose Side Effects)

UDL Digoxin Recall & Bertek Recall Lawsuits - Contact a Lawyer

If you or a loved one have been seriously injured or a loved one has died as a result of this digitalis toxicity or an overdose of Digitek Digoxin, UDL Digoxin or Bertek Digoxin, please call us immediately for a Free Digitek Toxicity Lawsuit Evaluation

Nationwide Help is Available

Digitek Recall Announced by FDA

Digitek Injury Lawsuits - Contact a Lawyer

[April 25, 2008 - Digitek Recall Press Release - Actavis Totowa LLC]

Digitek Recall Announced

Morristown, NJ -- April 25, 2008 -- Actavis Totowa LLC, a United States manufacturing division of the international generic pharmaceutical company Actavis Group, is initiating a Class I nationwide recall of DigitekŪ (digoxin tablets, USP, all strengths) for oral use. The products are distributed by Mylan Pharmaceuticals Inc., under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label. ( See:FDA Recall of Digitek)